GlassScriptPhysician profile
David S Hyler
NPI 1760468912
$1,143.29
in general payments reported to CMS, 2019-2025
21 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2021: $78.65 · 2022: $242 · 2023: $152 · 2024: $354 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.67 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $188.36 | 2019-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Optumhealth Care Solutions, LLC | $185.80 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Astellas Pharma US INC | $115.74 | 2023-2024 | Veozah |
| Shield Therapeutics INC | $69.06 | 2022-2024 | |
| Sage Therapeutics, LLC | $67.06 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $61.38 | 2025 | Myfembree |
| Pfizer INC. | $61.21 | 2022-2023 | |
| Abbvie INC. | $58.00 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.10 | 2022-2023 | |
| Exeltis, USA INC. | $49.60 | 2021-2022 | |
| Organon LLC | $45.71 | 2024 | |
| Scynexis, INC. | $42.21 | 2022 | |
| Mayne Pharma Commercial LLC | $29.45 | 2022 | |
| Novo Nordisk INC | $22.92 | 2019-2021 | |
| Allergan, INC. | $18.56 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $17.28 | 2021 | |
| Myovant Sciences INC. | $16.71 | 2022 | |
| Medtronic, INC. | $16.23 | 2021 | |
| Minerva Surgical, INC | $12.93 | 2022 | |
| Daiichi Sankyo INC. | $11.98 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hyler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.